“Development of Advanced Formulations with Improved Bioavailability”
- One prominent trend in the oral iron therapy for anemia market is the development of advanced formulations with improved bioavailability and fewer side effects. Traditional iron supplements often cause gastrointestinal discomfort, leading to poor patient compliance
- To address this, pharmaceutical companies are focusing on innovative formulations such as liposomal iron, heme iron polypeptides, and polysaccharide iron complexes, which enhance absorption while reducing adverse effects such as constipation and nausea
- For instance, in September 2023, a study published in the Journal of Clinical Medicine highlighted that liposomal iron supplements showed 30% higher absorption rates compared to conventional ferrous sulfate, with fewer reported side effects
- This shift towards patient-friendly formulations is expected to drive market growth, making oral iron therapy more accessible and effective for individuals suffering from anemia
